title: Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneumoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state.
abstract: Bacterial ghosts are empty cell envelopes achieved by the expression of a cloned bacteriophage lysis gene and, unlike classical bacterins, suffer no denaturing steps during their production. These properties may lead to a superior presentation of surface antigens to the immune system. Currently available porcine Actinobacillus pleuropneumoniae vaccines afford only minimal protection by decreasing mortality but not morbidity. Pigs which survive infection can still be carriers of the pathogen, so a herd once infected remains infected. Carrier pigs harbour A. pleuropneumoniae in their nasal cavities, in their tonsils, or within lung lesions. A dose-defined nose-only aerosol infection model for pigs was used to study the immunogenic and protective potential of systemic immunization with ghosts made from A. pleuropneumoniae serotype 9 reference strain CVI 13261 against an homologous aerogenous challenge. Pigs were vaccinated twice intramuscularly with a dose of 5x10(9) CFU ghosts (GVPs) or formalin-inactivated A. pleuropneumoniae bacterins (BVPs). After 2 weeks vaccinated pigs and non-vaccinated placebo controls (PCs) were challenged with a dose of 10(9) CFU by aerosol. The protective efficacy of immunization was evaluated by clinical, bacteriological, serological and post-mortem examinations. Bronchoalveolar lavage in pigs was performed during the experiment to obtain lavage samples (BALF) for assessment of local antibodies. Isotype-specific antibody responses in serum and BALF were determined by ELISAs based on whole-cell antigen. Immunization with ghosts did not cause clinical side-effects. After aerosol challenge PCs developed fever and pleuropneumonia. GVPs or BVPs were found to be fully protected against clinical disease or lung lesions in both vaccination groups, whereas colonization of the respiratory tract with A. pleuropneumoniae was only prevented in GVPs. Specific immunoglobins against A. pleuropneumoniae were not detectable in BALF after immunization. A significant systemic increase of IgM, IgA, IgG(Fc'), or IgG(H+L) antibodies reactive with A. pleuropneumoniae was measured in GVPs and BVPs when compared to the non-exposed controls. BVPs reached higher titers of IgG(Fc') and IgG(H+L) than GVPs. However, prevention of carrier state in GVPs coincided with a significant increase of serum IgA when compared to BVPs. These results suggest that immunization with ghosts, that bias antibody populations specific to non-denaturated surface antigens, may be more efficacious in protecting pigs against colonization and infection than bacterins.
authors.affiliation: Institute of Animal Hygiene and Veterinary Public Health, Veterinary Faculty, University of Leipzig, D-04103 Leipzig, Germany. hensel@vetmed.uni-leipzig.de
authors.forename: A
authors.initials: A
authors.lastname: Hensel
authors.forename: V
authors.initials: V
authors.lastname: Huter
authors.forename: A
authors.initials: A
authors.lastname: Katinger
authors.forename: P
authors.initials: P
authors.lastname: Raza
authors.forename: C
authors.initials: C
authors.lastname: Strnistschie
authors.forename: U
authors.initials: U
authors.lastname: Roesler
authors.forename: E
authors.initials: E
authors.lastname: Brand
authors.forename: W
authors.initials: W
authors.lastname: Lubitz
mesh_terms: D000189:Actinobacillus Infections / Q000517:prevention & control*; D016977:Actinobacillus pleuropneumoniae / Q000276:immunology*; D000336:Aerosols; D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis; D001428:Bacterial Vaccines / Q000276:immunology*; D002353:Carrier State / Q000517:prevention & control*; D007114:Immunization; D007132:Immunoglobulin Isotypes / Q000032:analysis; D007273:Injections, Intramuscular; D008168:Lung / Q000382:microbiology / Q000473:pathology; D008297:Male; D012703:Serotyping; D013552:Swine; D015164:Vaccines, Inactivated / Q000276:immunology
chemical_list: D000336:Aerosols; D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines; D007132:Immunoglobulin Isotypes; D015164:Vaccines, Inactivated